Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michel Levesque, Ph.D.

Concepts (13)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Michel Levesque's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Michel Levesque has written about over time.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1 publications between 2009 and 2009, average publication date June 2009. Animals, 1 publications between 2009 and 2009, average publication date June 2009. Antiparkinson Agents, 1 publications between 2009 and 2009, average publication date June 2009. Blood-Brain Barrier, 1 publications between 2009 and 2009, average publication date June 2009. Brain, 1 publications between 2009 and 2009, average publication date June 2009. Dyskinesia, Drug-Induced, 1 publications between 2009 and 2009, average publication date June 2009. Gadolinium DTPA, 1 publications between 2009 and 2009, average publication date June 2009. Levodopa, 1 publications between 2009 and 2009, average publication date June 2009. Macaca fascicularis, 1 publications between 2009 and 2009, average publication date June 2009. Magnetic Resonance Imaging, 1 publications between 2009 and 2009, average publication date June 2009. Male, 1 publications between 2009 and 2009, average publication date June 2009. Parkinsonian Disorders, 1 publications between 2009 and 2009, average publication date June 2009. Time Factors, 1 publications between 2009 and 2009, average publication date June 2009.

To see the data from this visualization as text, click here.
Levesque's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.